Hepatocellular carcinoma (HCC) is the most common malignant tumor of the liver characterized by high recurrence rate and high mortality. The interaction of oxidative stress tolerance and glycometabolism reprogramming in cancer cells results in metastasis and drug resistance in HCC. AMP-activated protein kinase (AMPK) is the master switch of cellular energy metabolism, which regulates the expression of glycolytic rate-limiting enzymes at multiple levels. SUMO Specific Peptidases (SENPs) respond to oxidative stress and modulate AMPK activity. Key scientific issues of this project: Activation of SENP5 by reactive oxygen species (ROS) triggered AMPKα2 de-SUMOylation and cytoplasmic retention to promote the Warburg effect in HCC cells. The human HCC cell lines SMMC-7721 and HepG2 were used in this project. H2O2 (200μM) was used to simulates oxidative stress in HCC cells. Glycolysis flow was monitored by Seahorse XF Extracellular Flux Analyzers. Western blot and immunofluorescence were used to evaluate expression and localization of AMPKα2. Data from TCGA database validated the correlation between SENP5 and glycolysis limiting enzymes. Results: (1) ROS-activated SNEP5 promoted Warburg effect; (2) SENP5 inhibited SUMO2/3 modification and nuclear translocation of AMPKα2; (3) Nuclear localized AMPKα2 activated FOXO3 to inhibit the Warburg effect mediated by c-Myc/Hif-α; (4) ROS activated SENP5 induced sorafenib resistance and epithelial mesenchymal transformation in HCC cells. Conclusion: SENP5 modifies the activation and localization of AMPK to promote glycometabolism reprogramming in HCC. This project provides a new theoretical bases for the treatment of HCC. Peptidase 5; Warburg effect Graphic abstract ROS activation of SENP5 mediates AMPKα2 de-SUMOylation and cytoplasmic retention, which promotes Warburg effect of liver cancer cells
Introduction
Primary liver cancer is the most common malignant tumor of the digestive system and the second leading cause of death of malignant tumor in China [1] . Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer, accounting for about 90%, with a high recurrence rate of metastasis, high mortality and poor prognosis. Clinically, the majority of HCC patients have been diagnosed in the middle and late stages, thus losing the opportunity for surgical treatment. The sensitivity of radiotherapy and chemotherapy for liver cancer is poor, and the situation of resistance to first-line targeted drugs such as sorafenib is serious [2] . It is urgent to further explore the molecular mechanism of the development of HCC.
Metabolic pathways of cancer are reprogrammed to meet the demands of bioenergy, biosynthesis, and redox homeostasis in rapid growing cells. The Warburg effect was first recognized in metabolic remodeling: energy production in aerobic environments is primarily dependent on glycolysis in tumor cells. Metabolic reprogramming occurs not only during the transformation of normal cells into tumor cells, but also during the development of advanced tumor cells and the self-renewal of tumor stem cells, which is closely related to the sensitivity of anticancer drugs and tumor metastasis potential [3] [4] [5] [6] . Multiple interactions between proto-oncogenes and tumor suppressor genes, including Hif-1, c-Myc, AMPK, and PI3K, co-mediate reprogramming of tumor metabolism. C-Myc and Hif-1 co-dissimilated mitochondrial tricarboxylic acid cycle to promote phospholipid, nucleotide and protein synthesis as well as the generation of reductive force [7] . This may serve as a conservative mechanism for metabolic reprogramming of tumor cells to maintain their proliferation.
Rapid cell proliferation leads to a relatively hypoxic-ischemic environment in solid tumors, which, together with immune factor stimulation, traditional chemoradiotherapy and new targeted drugs, can induce oxidative stress in tumor cells [8] .It has been confirmed that tumor cells have higher oxidative stress tolerance than normal cells [9] , suggesting that ROS in tumor cells may play a role in tumor development as signaling molecules rather than as injury mediators. There has been evidence that ROS can directly stabilize hif-1 production in tumor cells, independent of hypoxia [10] , suggesting that oxidative stress may be one of the mechanisms of metabolic reprogramming in tumor cells. The mechanism of intracellular oxidative stress tolerance and glucose metabolism reprogramming are the cause and effect of each other, which jointly drive tumor proliferation and drug resistance.
SENP5 is a SUMO protease regulated by oxidative stress [11] [12] [13] . SENP5 can specifically hydrolyze SUMO2/3 to reduce the SUMO-modification of target protein, affecting protein activity, subcellular localization and stability. It has been reported that SENP5 inhibits apoptosis and promotes cell survival under oxidative stress in liver cancer, oral cancer, breast cancer and osteosarcoma [14] [15] [16] [17] , but the mechanism is unclear. In SV40-transformed African green monkey kidney cells COS-7, it was confirmed that SENP5 regulated the SUMO-modification of mitochondrial fission protein Drp1, thereby affecting mitochondrial morphology and function [18] , suggesting that it had a metabolic regulation effect. AMPK is a cellular energy-sensing molecule that regulates synthesis and catabolic metabolism by monitoring the cellular AMP/ATP ratio [19] . As the master regulator of cellular energy metabolism, AMPK regulates the expression and activity of multiple rate-limiting enzymes that regulate glycolytic pathways at multiple levels including transcription, translation, and post-translation modification [20] . Both SUMO1 and SUMO2/3 modify the catalytic subunits of AMPK (α1, α2), and regulate their activity [21] [22] [23] . Based on the above theoretical basis, we propose the following key scientific hypothesis: ROS activates SENP5 and mediates AMPKα2 de-SUMOylation and cytoplasmic retention, thus promoting the Warburg effect of HCC cells.
Methods

Drugs and reagents
Seahorse XF glycolytic rate assay kit (103344-100) was purchased from Agilent Technologies (Santa Clara, California). MTT Cell Proliferation and Cytotoxicity Assay Kit (C0009) were purchased from Beyotime (Nanjing, PRC). The antibodies used in this study are: β-actin (ab179467), AMPKα1 (ab32047), AMPKα2 (ab3760), SENP5 (ab58420), PFKFB3 (ab181861), LDH-A (ab101562), p-AMPK (ab23875), c-Myc (ab32072), Hif-1α (ab1), SUMO2/3 (ab233222), Histone (ab1791), FOXO3 (ab12162), p-FOXO3 (ab47282), SIRT1 (ab220807), E-Cadherin (ab194982), N-Cadherin (ab18203), Vimentin (ab92547), Snail (ab229701), Donkey Anti-Goat IgG H&L(Cy5) (ab6566), Donkey Anti-Rabbit IgG H&L(HRP) (ab6802) were purchased from Abcam (Cambridge, UK).
Cell culture
SMMC-7721 and HepG2 hepatocellular carcinoma cell line was purchased from the cell bank of the Chinese academy of sciences. Cells were grown in Eagle's minimum essential medium containing 10% heat-inactivated fetal bovine serum (FBS) (Invitrogen, Carlsbad, CA), 100 U/ml of penicillin and 100 μg/ml of streptomycin in a humidified atmosphere of 5% CO2 at 37°C.
Cell viability assay
Cell viability was measured in different treatment groups with MTT Cell Proliferation and Cytotoxicity Assay Kit (Beyotime) according to the manufacturer's protocol.
Glycolysis flux analysis
Glycolysis flux were measured with Seahorse XF glycolytic rate assay kit (Agilent Technologies) by Seahorse XF Extracellular Flux Analyzers (Agilent Technologies) according to the manufacturer's protocol.
Western blotting and immunoprecipitation assay
Total proteins were extracted from chordoma cells following immunoprecipitation and immunoblotting according to the standard protocol. β-actin was used as the control of cell lysate protein. Histone was used as the control of nucleus lysate protein.
RNA isolation and qPCR analysis
Total RNA was isolated from microglia using TRIzol reagent (Invitrogen) according to the manufacturer's instructions. cDNA was transcribed and SYBR-Green-based real time quantitative PCR was performed according to the standard protocol.
Immunofluorescent staining
Immunofluorescence technique was used according to the standard protocol.
Statistical analyses
All data are presented as mean ± standard error of the mean (SEM). For experiments that involved two groups of samples, Student's unpaired t test was used. For experiments that involved multiple groups, one-way or two-way analysis of variance with repeated measures were used to assess group means.
Results
ROS activate SENP5 to promote Warburg effect of liver cancer cells
We used MTT experiment to investigate the effect of gradient concentration of H2O2 on the proliferation of SMMC-7721 hepatocellular carcinoma cells. The results showed that 200μM H2O2 significantly enhanced the proliferation of HCC cells, while 1mM H2O2 significantly inhibited the proliferation of HCC cells (Figure 1a ). This suggests that ROS at different concentrations can regulate the proliferation of tumor cells in a differentiated manner, and that 200μM H2O2 is the optimal concentration to stimulate the proliferation of liver cancer cells, which is consistent with other liver cancer research data. In the follow-up experiment, 200μM H2O2 stimulation was used to simulate the effect of oxidative stress on promoting cancer. Western blot showed increased expression of SENP5 in liver tumor cells stimulated by 200μM H2O2 (Figure 1b ). The expressions of glycolytic rate-limiting enzymes HK2, PFKFB3 and LDH-A were increased. Knockdown of SENP5 reduced the expression of glycolytic rate-limiting enzymes in liver cancer cells (Figure 1c ), suggesting ROS activated SENP5, which further induced glycolytic activation .Aerobic glycolysis mediated by
ROS-activated SENP5 of HCC cells was confirmed by Seahorse XF Extracellular Flux
Analyzers (Figure 1d ). Analysis of data from TCGA database of hepatocellular carcinoma patients showed that SENP5 expression in hepatocellular carcinoma tissues was significantly higher than that in adjacent tissues ( Figure 1e ). K-M survival analysis showed that the prognosis of patients with high expression of SENP5 was worse than that of patients with low expression of SENP5 ( Figure 1f ). Correlation analysis of gene expression showed that the high expression of SENP5 in hepatocellular carcinoma was positively correlated with the expression of HK2, PFKFB3 and LDH-A (Figure 1g -i). The above results showed that ROS induced the increased expression of SENP5, which mediated the increased expression of glycolytic rate-limiting enzyme and promoted the Warburg effect in HCC. (*p <0.05 vs Ctrl, n=6.)
SENP5 activates glycolysis by inhibiting AMPKα2 instead of AMPKα1 in HCC
Western blot results showed that ROS inhibited the expression of AMPKα1 and AMPKα2 in liver cancer cells, while the expression of AMPKα1 did not change significantly after SENP5 was knocked down, while the expression of AMPKα2 was significantly up-regulated ( Figure   2a ), suggesting that the AMPKα2 subunit was regulated by SENP5. To further clarify which α catalytic subunit of AMPK is involved in SENP5's regulation of glycolysis, we solely knocked down AMPKα1 and AMPKα2 subunits in liver cancer cells that knocked down SENP5, respectively, to observe cell proliferation activity and glycolysis flux changes. We found that the proliferation activity, glucose uptake and lactic acid production of liver cancer cells were not significantly changed after further knocking down AMPKα1 on the basis of 
SENP5 inhibits AMPKα2 SUMO2/3 modification to promote glycolysis in HCC
Co-immunoprecipitation showed interaction between SENP5 and AMPKα1 and AMPKα2, but the interaction between AMPKα2 and SENP5 increased under oxidative stress, while the interaction between AMPKα1 and SENP5 showed no significant change ( Figure 3a ). We further test whether SENP5 inhibits AMPKα2 SUMP2/3 modification.
Co-immunoprecipitation showed that ROS induced increased interaction between AMPKα2 and SENP5, while AMPKα2 SUMO2/3 modification decreased, along with the expression of p-AMPKα2 decreased. Knocking down SENP5 reverses these changes, suggesting that 
SENP5 inhibits AMPK 2 nuclear translocation and promotes glycolysis
SUMO modification can affect the activity and sub-cellular localization of the target protein.
To determine the effect of SUMO2/3 modification on AMPKα2, we detected AMPKα2 subcellular localization by immunofluorescence. We found that knocking down SENP5 under oxidative stress caused AMPKα2 to enter the nucleus (Figure 4a ). Western blot also confirmed the entry of AMPKα2 into the nucleus after nucleus-cytoplasm separation ( Figure   4b ). Furthermore, the immunoprecipitation of protein after nucleus-cytoplasm separation revealed a small amount of AMPKα2 in the nucleus during oxidative stress, with extremely low SUMO2/3 modification and minimal phosphorylation. SUMO2/3 modification of AMPKα2 was significantly increased and phosphorylation of AMPKα2 was increased in the nucleus after SENP5 was knocked down (Figure 4c ). The results in cytoplasm showed the opposite changes as the results in the nucleus: SUMO2/3 modification and phosphorylation of AMPKα2 in the cytoplasm were reduced after SENP5 was knocked down (Figure 4d ). (Figure 4g ), suggesting that SUMO2/3 modification mediated AMPKα2 nuclear translocation was the key to inhibit glycolysis in HCC.
Nuclear localized AMPKα2 inhibits c-Myc/Hif-1 expression by activating FOXO3 in HCC
To further explore how nuclear AMPKα2 inhibited glycolysis, western blot found that 
Discussion
HCC is one of the deadliest malignancies. About 383000 people die of HCC in China every
year, accounting for 51% of the number of HCC deaths in the world [1] . China has been carrying out large-scale liver cancer research for nearly 20 years. Although some achievements have been made in terms of morbidity and mortality, there is still a long way to go between the research progress of existing primary liver cancer and the conquest of liver cancer. The most important bottleneck lies in the metastasis and recurrence of liver cancer.
The metastasis of liver cancer is closely related to the metabolism of cancer cells. Existing studies have shown that sugar metabolism reprogramming of cancer cells is an important factor in cancer cell metastasis [24] . A hundred years ago, Dr. Warburg observed that cancer cells energize themselves through glycolysis with relatively low energy production rather than oxidative phosphorylation, even though cancer cells have complete mitochondrial function [25] . Studies have shown that the oxygen consumption of cells is significantly reduced after canceration, mitochondrial oxidative function accounts for only 5% of the total energy of cells, increased glucose intake, increased lactate secretion, and increased microenvironmental acidity, which are believed to directly promote the attack of cancer metastasis [26] [27] [28] . The malignant metastasis stage of cancer cells has a very high glycolysis rate. Therefore, a number of anticancer drugs targeting glycolysis of cancer cells have been widely used in clinical practice, and their significant inhibitory effect on glycolysis process has been proved to be effective in inhibiting cancer metastasis [29, 30] . All the above suggested that the abnormal increase of glycolysis in cancer cells could promote the migration of cancer cells. Targeting the abnormal glycolysis process is of great significance for the study of tumor metabolism and the search for new targets for the inhibition of cancer metastasis. During the process from the occurrence of liver cancer to the gradual malignant transformation, solid tumors gradually form, and most of the cells in the tumor are in the environment of relative hypoxia and ischemia. At the same time, cancer cells entering the metastasis stage will aggravate their hypoxia and ischemia degree due to their malignant proliferation and growth. It is generally believed that cancer cells will stress to produce ROS under hypoxia conditions, which makes cancer cells under relative oxidative stress conditions, causing metabolic reprogramming [31] . Previous studies have proved that ROS can directly stabilize hypoxia-inducing factor Hif1α without relying on hypoxia [32] , which, as an important regulatory molecule of cells under oxidative stress, can affect multiple metabolic pathways, including glycolysis and autophagy, suggesting an important role of ROS in tumor energy metabolism. Studies have also demonstrated that different degrees of oxidative stress can activate AMPK through different molecular mechano-dependent pathways and ultimately affect glucose metabolism [33] , suggesting that oxidative microenvironment regulates AMPK molecules conditionally. These studies suggest that excess ROS caused by hypoxia in metastatic cancer cells is closely related to the effect of AMPK on glucose metabolism. Our study found that ROS-mediated AMPK deSUMOylation through SENP5 lead to glycolysis and ultimately promote metastasis of HCC, suggesting that AMPK SUMOylation is a metabolic regulatory target for liver cancer cell metastasis.
AMPK is an important regulator of cell energy metabolism and is thought to play an important role in the development of cancer cells. Research has shown that AMPK can influence the expression of cell speed limit glycolytic key enzyme levels, but paradoxically, AMPK in cancer cells and normal cells in the glycolysis is not consistent: although AMPK activation in normal cells will promote glycolysis [35] , but most studies have shown that international AMPK as glycolysis inhibitory factor exists in the cancer cells [33, 34] , the activation of AMPK in normal cells will promote glycolysis [35] . Similarly, AMPK activation also inhibits metastasis of cancer cells, including through the following pathways:
UBE2O-AMPKα2, AMPK-mTOR, AMPK-p65 and NF-κB/Upa/MMP9 [35] [36] [37] . It is known that the Warburg effect of cancer cells promotes cancer metastasis, while AMPK in cancer cells can inhibit glycolysis and thus tumor metastasis, suggesting that targeting the effect of AMPK on glycolysis may provide guidance for targeted inhibition of cancer metastasis.
These studies all suggest that the paradoxes of AMPK in glycolysis in cancer cells and normal cells may be due to conditioned differences in the modulation of AMPK in different oxidative environments. ROS can affect AMPK activity, but there are different literature reports on which way ROS activates AMPK. Several studies have reported that ROS activation is accompanied by a decrease in ATP content, and ROS activates AMPK in an amp-dependent manner, but the mechanism is unclear [38] . It has also been reported that ROS can be directly redox modified to activate AMPK independent of AMP/ATP charge ratio [39] . These results suggest that ROS may have different mechanisms for the activation of AMPK, but no studies have explored the causes.
SUMOylation affects AMPK activity. Ubiquitin-like proteins are a class of proteins that are very similar to the tertiary structure of the amino acids of ubiquitin, including hSmt3, UBL1, PIC1, Sentrin, GMP1 etc., collectively known as SUMO [40, 41] . SUMO plays an important role in maintaining genomic stability, mediating protein-protein interactions, regulating intracellular localization of proteins, regulating transcription factor activity, and participating in signal transduction and DNA damage repair. There are three kinds in human body:
SUMO1, SUMO2 and SUMO3. SUMO2 is very similar to SUMO3 in structure and can form double chains. Different from ubiquitination, SUMO modification does not necessarily cause protein degradation, but can affect the location of subcells and interactions between proteins, thus enhancing protein stability and activity [40, 42] . Teresa Rubio discovered in 2013 that there was a competitive relationship between SUMO and ubiquitin modification of proteins.
SUMO modification of AMPK subunit 2 by E3-SUMO2 ligase PIASy inhibited AMPK binding by ubiquitin and improved the overall activity of AMPK [43] . At present, there are few studies on the effect of ubiquitin-like modification on AMPK regulation, and there are still contradictions. In 2015, Cell Report reported that cells can enhance AMPK activity by modifying LKB1 with SUMO1 [44] . However, a paper published in Nature Communications in 2015 showed that SUMO's E3 ligase PIAS4 could inhibit the activity of AMPK group subunits by catalyzing SUMO activation [45] . But why multiple sumo-modified pathways lead to the opposite of AMPK activity is unknown. Our study found that ROS activated SENP5 regulates cellular nuclear localization and activation of AMPKα2 as the de-SUMOylation enzyme, and ultimately affects glycolysis of liver cancer cells, providing new experimental evidence for ROS to regulate SUMOylation of AMPK.
Conclusions
We found that AMPKα2 nuclear translocation excited FOXO3 is the key mechanism for its inhibition of glycolysis in HCC. SENP5 activated by ROS inhibits the modification of AMPKα2 SUMOylation, resulting in cytoplasmic retention of AMPKα2 and promoting the Warburg effect of liver cancer cells. ROS/SENP5/AMPK pathway induces sorafenib resistance and epithelial mesenchymal transformation in HCC.
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